Table 1 Information on data included in the study
Phenotypes/ID | Data source | Study information/PMID | Cases/controls | Author/Year |
|---|---|---|---|---|
T1D: ebi-a-GCST010681 | 12 cohorts# | European /32,005,708 | 9266/15,574 | Forgetta V/2020 |
T1D: ebi-a-GCST90018925 | UKB, Finnish database | European/34,594,039 | 6447/451,248 | NA/2022 |
T1D with complications: DM1NASCOMP | Finnish database | European | 6234/308,280 | NA/2022 |
T1D without complications: E4_DM1NOCOMP | Finnish database | European | 4918/183,185 | NA/2021 |
T1D with renal complications: E4_DM1REN | Finnish database | European | 1579/308,280 | NA/2022 |
T1D with ketoacidosis: E4_DM1KETO | Finnish database | European | 2102/308,280 | NA/2022 |
T1D with coma: E4_DM1COMA | Finnish database | European | 2050/308,280 | NA/2022 |
T1D with neurological complications: E4_DM1NEU | Finnish database | European | 1077/308,280 | NA/2022 |
T1D with peripheral circulatory complications: E4_DM1PERIPH | Finnish database | European | 669/308,280 | NA/2022 |
T1D with ophthalmic complications: E4_DM1OPTH | Finnish database | European | 5202/308,280 | NA/2022 |
Non-ischemic cardiomyopathy: finn-b-I9_NONISCHCARDMYOP | Finnish database | European | 11,400/175,752 | NA/2022 |
Hypertension: ukb-b-12,493 | UKB | European | 54,358/408,652 | 2018/Ben Elsworth |
Body mass index: ukb-b-19,953 | UKB | European | 461,460 | 2018/Ben Elsworth |
Monokine Induced by Gamma Interferon | YFS and FINRISK 1997 and 2002 | European/33,491,305 | 8293 | 2020/Vanessa Tan |